Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy
 |
Patients with HR-positive breast cancer can use fertility preservation and assisted reproductive technologies (ART) to conceive without an increased short-term risk of recurrence.
|
Follow-up data are needed to monitor long-term disease outcomes. We plan to continue to follow the study participants until 2029, but FUNDING IS NEEDED. THANK YOU for supporting the crucial continuation of the POSITIVE study! DONATE
 |
TWINT Scan the QR code (image on the left) with the Twint app on your mobile phone (Scan & Pay) and follow the instructions in the Twint app. |
The study is sponsored and conducted globally by the International Breast Cancer Study Group (IBCSG), a division of the ETOP IBCSG Partners Foundation based in Bern, and by the Alliance for Clinical Trials in Oncology in North America in collaboration with the Breast International Group (BIG). Patients from 116 hospitals in 20 countries on 4 continents and 11 research collaborative Groups participated in the study.
 |
THANK YOU to our POSITIVE patients and their families and to all our supporters! |
Donating & Supporting